US87319A - Improved medicated cigar - Google Patents
Improved medicated cigar Download PDFInfo
- Publication number
- US87319A US87319A US87319DA US87319A US 87319 A US87319 A US 87319A US 87319D A US87319D A US 87319DA US 87319 A US87319 A US 87319A
- Authority
- US
- United States
- Prior art keywords
- cigar
- parts
- medicated
- improved
- improved medicated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000019506 cigar Nutrition 0.000 title description 11
- 235000002711 Piper cubeba Nutrition 0.000 description 5
- 240000003731 Piper cubeba Species 0.000 description 5
- 241000208125 Nicotiana Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DIYWRNLYKJKHAM-MDOVXXIYSA-N (-)-cubebin Chemical compound C1=C2OCOC2=CC(C[C@@H]2[C@@H](CC=3C=C4OCOC4=CC=3)CO[C@@H]2O)=C1 DIYWRNLYKJKHAM-MDOVXXIYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000252141 Semionotiformes Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- XUEHVOLRMXNRKQ-KHMAMNHCSA-N alpha cubebene Natural products CC(C)[C@@H]([C@H]12)CC[C@@H](C)[C@]32[C@@H]1C(C)=CC3 XUEHVOLRMXNRKQ-KHMAMNHCSA-N 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012261 resinous substance Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Definitions
- cnbebs A chemical analysis of cnbebs shows that they contain, to lthe hundred pounds, about 15 parts of water, 4.88 parts of oil of cubebs, .36 parts of resin, 3.69 parts of wax, 6.53 parts of eXtractive substance, 6.12 parts of cubebin, 59.58 parts of woody fibre, and 3.84 parts of chloride of sodium, sulphate and phosphate of lime, and magnesa.
- This proportion ofthe above-named ingredients, except the water, may be compounded, ground, and sprin kled on the filling of the cigar when it is being rolled or formed, in the same manner as the-ground cubebs, as
- the diseases which the medicated cigar is most sure to relieve are catarrh, bronchitis, dyspepsia, consumption, whooping-cough, and aiiections ofthe kidneys and urinary organs. And. for these purposes it is foundto be much better than to give cubebs in any'form now known to the profession.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
, tant @anni Lem/rs 12a/:em No. 87,320 dated Mai/rch. 2,l le@ R ...WM
IMPROVED IMEDICATED CIG-AR. l
The Schedule referred in these Lettera Patent and makingpart of the same.
To all whom 'it may concern Be it known thatI, JOSEPH` BARRETT, voi'Chicago,`
in the county of Cook, and State of lllinois, have invented an Improved Medicated Cigar; and I do hereby declare that the following is a full, clear, and exact description thereof, which will enable others to prepare the'cigar for use;
I take so much tobacco as` is necessary to make a good cigar, and when rolling the'lcaves of the filling together, sprinkle in evenly so much finely-pulverized cnbebs asare equal in Weight to about one-eighth ofy the weight of tobacco. The wrapper is then put on inthe usual manner, and thercigar is ready for use. Its flavor, however, will be much improved, if' it shall he first allowed to season for a month or two.
A chemical analysis of cnbebs shows that they contain, to lthe hundred pounds, about 15 parts of water, 4.88 parts of oil of cubebs, .36 parts of resin, 3.69 parts of wax, 6.53 parts of eXtractive substance, 6.12 parts of cubebin, 59.58 parts of woody fibre, and 3.84 parts of chloride of sodium, sulphate and phosphate of lime, and magnesa.
This proportion ofthe above-named ingredients, except the water, may be compounded, ground, and sprin kled on the filling of the cigar when it is being rolled or formed, in the same manner as the-ground cubebs, as
, they will produce, if the cigar does not season too long,
substantially the same effect.
When the oil is used, it being volatile after it is eX- tracted from the resinous substance, it soon mostly `evaporates, and leaves the cigar only partially medicated.
Further, experiments prove that the extractiva substance, although its component parts are unknown to me, produces a much more salutary effect, when used in the 'natural state, than when used with the other parts, after once having been separated'frorn'them.
The medicinal eii'ect of cubebs, in the treatment ofl various diseases, is well known to the medical profes sion.
The diseases which the medicated cigar is most sure to relieve, are catarrh, bronchitis, dyspepsia, consumption, whooping-cough, and aiiections ofthe kidneys and urinary organs. And. for these purposes it is foundto be much better than to give cubebs in any'form now known to the profession.
The powerful narcotic eiects of the oil of tobacco are almost entirely neutralized by the burning cubebs;
consequently the-tobacco is not only rendered harmless, but made to subserve a useful purpose in counter- 'laying irritation and quieting the nervous system'. i No instruction can be given as to the number of ci-L gars to be smoked to relieve any of' the above-named diicultics. In case of a bad cold or hoarseness, one or two cigars smoked daily will be found sniiicient, butfor chronic affections, three or four should be used, andfor catarrh, the smoke should be ejected outwardly, i through the nose, if possible. If a greater number of cigars is used daily, no evil effect will be produced.
Having thus fully described my invention,
What I claim, and desire to secure by Letters Pat ent of the UnitedStates, is
A cigar, medicated with. the compound herein nained, as and for the purpose set forth.
Josnrn BARRETT.
Witnesses G. L. CHAPLN, E. E. GIBSON.
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US87319A true US87319A (en) | 1869-03-02 |
Family
ID=2156804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US87319D Expired - Lifetime US87319A (en) | Improved medicated cigar |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US87319A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846556A (en) * | 1996-06-14 | 1998-12-08 | Brooks; Bradley S. | Inhalant for reducing stress and method of use |
| US20040129270A1 (en) * | 2002-08-20 | 2004-07-08 | Aga Linde Healthcare | Method and devices for administration of therapeutic gases |
| US20050028816A1 (en) * | 2002-08-20 | 2005-02-10 | Aga Linde Healthcare | Methods for easing pain and anxiety from atrial or ventricular defibrillation |
-
0
- US US87319D patent/US87319A/en not_active Expired - Lifetime
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846556A (en) * | 1996-06-14 | 1998-12-08 | Brooks; Bradley S. | Inhalant for reducing stress and method of use |
| US20040129270A1 (en) * | 2002-08-20 | 2004-07-08 | Aga Linde Healthcare | Method and devices for administration of therapeutic gases |
| US20050028816A1 (en) * | 2002-08-20 | 2005-02-10 | Aga Linde Healthcare | Methods for easing pain and anxiety from atrial or ventricular defibrillation |
| US20070068523A1 (en) * | 2002-08-20 | 2007-03-29 | Aga Ab | Method for administration of therapeutic gases |
| US7337776B2 (en) | 2002-08-20 | 2008-03-04 | Aga Ab | Methods for easing pain and anxiety from atrial or ventricular defibrillation |
| US20090044804A1 (en) * | 2002-08-20 | 2009-02-19 | Aga Linde Healthcare | Method and devices for administration of therapeutic gases |
| US20090065001A1 (en) * | 2002-08-20 | 2009-03-12 | Aga Linde Healthcare | Method and devices for administration of therapeutic gases |
| US20090071475A1 (en) * | 2002-08-20 | 2009-03-19 | Aga Linde Healthcare | Method and devices for administration of therapeutic gases |
| US20090071481A1 (en) * | 2002-08-20 | 2009-03-19 | Aga Linde Healthcare | Method and devices for administration of therapeutic gases |
| US20090071474A1 (en) * | 2002-08-20 | 2009-03-19 | Aga Linde Healthcare | Method and devices for administration of therapeutic gases |
| US7681572B2 (en) | 2002-08-20 | 2010-03-23 | Aga Ab | Method and devices for administration of therapeutic gases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4694842A (en) | Tea-containing tobacco | |
| US87319A (en) | Improved medicated cigar | |
| DE3067665D1 (en) | Flavourant composition for tobacco, method for its production and tobacco product containing said composition | |
| Hong et al. | Biologically active compounds present in tobacco smoke: potential interactions between smoking and mental health | |
| CN106723344A (en) | Application of the disodium hydrogen phosphate in main flume temperature is reduced and it is added with the cigarette filter of disodium hydrogen phosphate | |
| US3525582A (en) | Smoking tobacco charge incorporating encapsulated vitamin a and mode of introduction | |
| US20040103908A1 (en) | Herbal cigarette | |
| Hillyer | The Lamb in the Apocalypse | |
| US87320A (en) | Improved medicated cigar | |
| Singh et al. | Breath carbon monoxide levels in different forms of smoking | |
| Jackson | Heavy smoking and sodium chloride hypogeusia | |
| Foxx et al. | Nicotine fading and self-monitoring for cigarette abstinence or controlled smoking: A two and one-half year follow-up. | |
| Singh et al. | Occupational health problems amongst women beedi rollers in Jhansi, Bundelkhand Region, Uttar Pradesh | |
| Keen et al. | Decline of tissue noradrenaline under the influence of a mitotic inhibitor | |
| US2164030A (en) | Process for curing plant foliage | |
| US197973A (en) | Improvement in medical compounds | |
| US112329A (en) | Improvement in medical compounds for cure of catarrh and asthma | |
| US55911A (en) | Improved medical compound | |
| US95858A (en) | Improved medicated cigar | |
| KR980000202A (en) | Manufacturing method of mugwort tobacco using mugwort as raw material | |
| Christie | On inhaling the smoke of datura in asthma | |
| Cohen | A combined approach using meditation-hypnosis and behavioral techniques in the treatment of smoking behavior: Case studies of five stressed patients. | |
| US213431A (en) | Improvement in medical cigarettes | |
| US111711A (en) | Improvement in medicated sivioking-tobaccos | |
| Akhmedov et al. | COUNTERACTING VAPING AS A SOCIALLY NEGATIVE PHENOMENON |